ALYREF and hepatocellular carcinoma: ALYREF,31 CDKN3,32 KIF3A,33 MCM10,34 RRM2,35 COLEC10,36 CPEB3,37 and PBLD38,39 have been reported to play critical roles in the progression and prognosis of HCC.